- Previous Close
197.00 - Open
197.40 - Bid 196.60 x 391200
- Ask 197.00 x 721000
- Day's Range
194.60 - 197.40 - 52 Week Range
171.80 - 209.50 - Volume
14,375 - Avg. Volume
140,980 - Market Cap (intraday)
19.612B - Beta (5Y Monthly) 0.51
- PE Ratio (TTM)
23.88 - EPS (TTM)
8.25 - Earnings Date Apr 30, 2025
- Forward Dividend & Yield 3.75 (1.91%)
- Ex-Dividend Date Apr 12, 2024
- 1y Target Est
228.60
Borregaard ASA engages in the development, production, and marketing of specialized biomaterials and biochemicals in Norway, rest of Europe, the United States, Asia, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers for various applications, such as agrochemicals, batteries, industrial binders, and construction; and biovanillin for flavor and fragrance companies, as well as for food and beverage industry. The BioMaterials segment offers specialty cellulose for use as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products; and cellulose fibrils for industrial applications. The Fine Chemicals segment provides fine chemical intermediates for contrast agents; and advanced bioethanol products. Borregaard ASA was incorporated in 2012 and is headquartered in Sarpsborg, Norway.
www.borregaard.com1,127
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BRG.OL
View MorePerformance Overview: BRG.OL
Trailing total returns as of 2/6/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BRG.OL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BRG.OL
View MoreValuation Measures
Market Cap
19.61B
Enterprise Value
21.85B
Trailing P/E
23.88
Forward P/E
18.35
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.58
Price/Book (mrq)
3.89
Enterprise Value/Revenue
2.87
Enterprise Value/EBITDA
11.85
Financial Highlights
Profitability and Income Statement
Profit Margin
10.87%
Return on Assets (ttm)
8.61%
Return on Equity (ttm)
16.43%
Revenue (ttm)
7.48B
Net Income Avi to Common (ttm)
813M
Diluted EPS (ttm)
8.25
Balance Sheet and Cash Flow
Total Cash (mrq)
172M
Total Debt/Equity (mrq)
43.74%
Levered Free Cash Flow (ttm)
310.5M